描述 |
Quinidine sulfate dihydrate 是一种有效且选择性的细胞色素 P450db (cytochrome P450db) 抑制剂,可在体内抑制苯丙胺的代谢。Quinidine sulfate dihydrate 增强长春新碱 (VCR) 在肿瘤细胞中的细胞毒性,尤其是在 P388 白血病 (P388/VCR) 和人骨髓性白血病的VCR 耐药亚型中。 |
---|---|
相关类别 |
|
靶点 |
IC50: cytochrome P450db; amphetamine metabolism[1]
|
SMILES |
O=S(O)(O)=O.[H]O[H].C=C[C@H]1C[N@](CC[C@H]1C2)[C@@]2(C)[C@@H](O)C3=CC=NC4=CC=C(OC)C=C34.[0.5] |
参考文献 |
|
沸点 | 992.5?C at 760 mmHg |
---|---|
熔点 | 212-214?°C (dec.)(lit.) |
分子式 | C20H24N2O2.1/2H2O4S.H2O |
分子量 | 782.943 |
闪点 | 554?C |
精确质量 | 782.356079 |
PSA | 192.62000 |
LogP | 6.52160 |
折射率 | 275 ° (C=2, 0.1mol/L HCl) |
|
硫酸奎尼丁二水合物毒性英文版
|
符号 |
GHS07 |
---|---|
信号词 |
Warning |
危害声明 |
H302 |
警示性声明 |
P301 + P312 + P330 |
个人防护装备 |
dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) |
Xn |
风险声明 (欧洲) |
R22 |
安全声明 (欧洲) |
13-36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | VA5605000 |
Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein. Antimicrob. Agents Chemother. 58(6) , 3168-76, (2014)
Predicting drug-drug interactions (DDIs) related to cytochrome P450 (CYP), such as CYP3A4 and one of the major drug transporters, P-glycoprotein (P-gp), is crucial in the development of future chemoth…
|
|
Diurnal variation in P-glycoprotein-mediated transport and cerebrospinal fluid turnover in the brain. AAPS J. 16(5) , 1029-37, (2014)
Nearly all bodily processes exhibit circadian rhythmicity. As a consequence, the pharmacokinetic and pharmacodynamic properties of a drug may also vary with time of day. The objective of this study wa…
|
|
Effects of the inhibition of intestinal P-glycoprotein on aliskiren pharmacokinetics in cynomolgus monkeys. Biopharm. Drug Dispos. 36(1) , 15-33, (2015)
Aliskiren is a substrate for P-glycoprotein (P-gp) and is metabolized via cytochrome P450 3A4 (CYP3A4). The aim of the present study was to assess whether P-gp influenced the pharmacokinetics of alisk…
|
|
Quinidine Sulfate Dihydrate |
Cinchonan-9-ol, 6′-methoxy-, (9S)-, sulfate, hydrate (2:1:2) (salt) |
EINECS 200-046-3 |
(9S)-6′-Methoxycinchonan-9-ol sulfate hydrate (2:1:2) |
MFCD00149346 |